| Antibody-Targeted Lipid Nanoparticles Reach High Cancer Therapy Efficacy With CRISPR-Cas9 »As far as we are aware, these findings represent the highest survival improvement in this aggressive tumour after a single treatment,« says Dan Peer about the new ground-breaking results from his lab. With a new lipid nanoparticle delivery system, his team in Tel Aviv has now achieved up to 70% gene editing in vivo in brain and ovarian cancers, resulting in significantly increased survival in mice. | |
